ADMA Biologics

ADMA

Capitalización de mercado USD 2937 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Aisling Capital New York	USD 11.1 M	–	–	–
2	BCM 2 Biomark Capital Management Greenwich, Connecticut	USD 4.42 M	–	–	–
3	3 Consonance Capital Management New York	USD 3.92 M	–	–	–
4	4 Perceptive Advisors New York	USD 2.22 M	–	–	–
5	IHM 5 Iguana Healthcare Management New York	USD 1.74 M	+USD 1.38 M	+415,000	+277%
6	6 Fidelity Investments Boston, Massachusetts	USD 1.15 M	-USD 49.3 k	-14,800	-4%
7	7 Vanguard Group Malvern, Pennsylvania	USD 960 k	+USD 538 k	+161,486	+108%
8	8 Prelude Capital Management New York	USD 120 k	+USD 12.8 k	+3,853	+11%
9	9 Bank of New York Mellon New York	USD 66 k	–	–	–
10	10 Geode Capital Management Boston, Massachusetts	USD 66 k	–	–	–
11	11 Renaissance Technologies New York	USD 63 k	+USD 30 k	+9,000	+80%
12	12 Millennium Management New York	USD 59 k	+USD 63.5 k	+19,078	Nuevas
13	13 BlackRock New York	USD 50 k	-USD 2.89 k	-869	-5%
14	14 Tower Research Capital (TRC) New York	USD 36 k	+USD 35.1 k	+10,532	+923%
15	15 Northern Trust Chicago, Illinois	USD 33 k	–	–	–
16	16 Morgan Stanley New York	USD 15 k	-USD 11.2 k	-3,374	-41%
17	17 UBS Group Zurich, Switzerland	USD 10 k	+USD 11.3 k	+3,400	Nuevas
18	18 Broadfin Capital New York	–	-USD 2.52 M	-681,346	Cerradas
19	19 Franklin Resources San Mateo, California	–	-USD 1.34 M	-348,870	Cerradas
20	20 Weiss Multi-Strategy Advisers New York	–	-USD 74 k	-20,000	Cerradas
21	21 Spark Investment Management New York	–	-USD 39 k	-10,700	Cerradas
22	22 Royal Bank of Canada Toronto, Ontario, Canada	–	+USD 7	+2	Nuevas
23	23 Bank of America Charlotte, North Carolina	–	+USD 13	+4	Nuevas

ADMA Biologics ADMA Capitalización de mercado USD 2937 M

ADMA Biologics

ADMA

Capitalización de mercado USD 2937 M